Abstract
Purpose
Localized prostate cancer (LPC) patients are faced with numerous treatment options, including observation or watchful waiting. The choice of treatment largely depends on their baseline health-adjusted life expectancy (HALE). By consensus, physicians recommend treatment if the patient’s HALE is ten or more years. However, the estimation of HALE is difficult. Although subjective by nature, self-rated health (SRH) is a robust predictor of mortality. We studied the usefulness of SRH in estimating HALE in patients who are considering treatment for LPC.
Methods
A total of 144 LPC patients from a large urology private practice in Norfolk, Virginia, were surveyed before they had chosen a treatment option.
Results
HALE determined by SRH correlated well with objective health measures and was higher than age-based life expectancy by an average of 2 years. The observed difference in life expectancy due to SRH adjustment was higher among patients with a better socioeconomic and health profile.
Conclusions
SRH is an easy-to-use indicator of HALE in LPC patients. A table for HALE estimation by age and SRH is provided for men aged 70–80 years. Additional research with larger samples and prospective study designs are needed before the SRH method can be used in primary care and urology settings.
Similar content being viewed by others
Abbreviations
- BRFSS:
-
Behavioral Risk Factor Surveillance Systems
- CCI:
-
Charlson comorbidity index
- CDC:
-
Centers for Disease Control and Prevention
- DASI:
-
Duke Activity Status Index
- HAD:
-
Hospital Anxiety and Depression
- HALE:
-
Health-adjusted life expectancy
- HRQOL:
-
Health-related quality of life
- LPC:
-
Localized prostate cancer
- METS:
-
Metabolic Equivalents
- MOS-SSS:
-
Medical Outcomes Study Social Support Scale
- NCCN:
-
National Comprehensive Cancer Network
- PSA:
-
Prostate-specific antigen
- SRH:
-
Self-rated health
- NHANES:
-
National Health and Nutrition Examination Surveys
References
Harlan, S. R., Cooperberg, M. R., Elkin, E. P., Lubeck, D. P., Meng, M. V., Mehta, S. S., et al. (2003). Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from CaPSURE. The Journal of urology, 170(5), 1804–1807.
Parker, C., Muston, D., Melia, J., Moss, S., & Dearnaley, D. (2006). A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. British Journal of Cancer, 94(10), 1361–1368.
Wilson, J. R., Clarke, M. G., Ewings, P., Graham, J. D., & MacDonagh, R. (2005). The assessment of patient life-expectancy: How accurate are urologists and oncologists? BJU International, 95(6), 794–798.
Taichman, R. S., Loberg, R. D., Mehra, R., & Pienta, K. J. (2007). The evolving biology and treatment of prostate cancer. The Journal of Clinical Investigation, 117(9), 2351–2361.
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007). Cancer statistics, 2007. CA: A Cancer Journal for Clinicians, 57(1), 43–66.
Klotz, L. (2005). Active surveillance for prostate cancer: For whom? Journal of Clinical Oncology, 23(32), 8165–8169.
Post, P. N., Hansen, B. E., Kil, P. J., Janssen-Heijnen, M. L., & Coebergh, J. W. (2001). The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: A population-based study. BJU International, 87(9), 821–826.
van den Bergh, R. C., Roemeling, S., Roobol, M. J., Aus, G., Hugosson, J., Rannikko, A. S., Tammela, T. L., Bangma, C. H., & Schroder, F. H. (2008). Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. European Urology.
Ruchlin, H. S., & Pellissier, J. M. (2001). An economic overview of prostate carcinoma. Cancer, 92(11), 2796–2810.
Miller, D. C., Gruber, S. B., Hollenbeck, B. K., Montie, J. E., & Wei, J. T. (2006). Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. Journal of the National Cancer Institute, 98(16), 1134–1141.
Dahm, P., Kunz, R., & Schunemann, H. (2007). Evidence-based clinical practice guidelines for prostate cancer: The need for a unified approach. Current Opinion in Urology, 17(3), 200–207.
McCloskey, S. A., & Kuettel, M. R. (2007). Counterpoint: Prostate cancer life expectancy can not be accurately predicted from currently available tools. Journal of the National Comprehensive Cancer Network, 5(7), 709–713.
Kistler, C. E., Lewis, C. L., Amick, H. R., Bynum, D. L., Walter, L. C., & Watson, L. C. (2006). Older adults’ beliefs about physician-estimated life expectancy: A cross-sectional survey. BMC Family Practice, 7, 9.
Walz, J., Gallina, A., Hutterer, G., Perrotte, P., Shariat, S. F., Graefen, M., et al. (2007). Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 69(1), 88–94.
Walter, L. C., & Covinsky, K. E. (2001). Cancer screening in elderly patients: A framework for individualized decision making. JAMA, 285(21), 2750–2756.
Cohen, H., & Britten, N. (2003). Who decides about prostate cancer treatment? A qualitative study. Family Practice, 20(6), 724–729.
Welch, H. G., Albertsen, P. C., Nease, R. F., Bubolz, T. A., & Wasson, J. H. (1996). Estimating treatment benefits for the elderly: The effect of competing risks. Annals of Internal Medicine, 124(6), 577–584.
Mohan, R., Beydoun, H., Barnes-Ely, M. L., Lee, L., Davis, J. W., Lance, R., et al. (2009). Patients’ survival expectations before localized prostate cancer treatment by treatment status. Journal of the American Board of Family Medicine, 22(3), 247–256.
NCHS. (2007). In National Vital Statistics Report 54 (14). 28 March 2007.
Fowler, F. J., Jr., McNaughton Collins, M., Albertsen, P. C., Zietman, A., Elliott, D. B., & Barry, M. J. (2000). Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA, 283(24), 3217–3222.
Potosky, A. L., Harlan, L. C., Stanford, J. L., Gilliland, F. D., Hamilton, A. S., Albertsen, P. C., et al. (1999). Prostate cancer practice patterns and quality of life: The prostate cancer outcomes study. Journal of the National Cancer Institute, 91(20), 1719–1724.
Chaudhry, S., Jin, L., & Meltzer, D. (2005). Use of a self-report-generated Charlson comorbidity index for predicting mortality. Medical Care, 43(6), 607–615.
Hlatky, M. A., Boineau, R. E., Higginbotham, M. B., Lee, K. L., Mark, D. B., Califf, R. M., et al. (1989). A brief self-administered questionnaire to determine functional capacity (The duke activity status index). The American journal of cardiology, 64(10), 651–654.
Hamilton, D. M., & Haennel, R. G. (2000). Validity and reliability of the 6 min walk test in a cardiac rehabilitation population. Journal of Cardiopulmonary Rehabilitation, 20(3), 156–164.
Lee, I. M., Hsieh, C. C., & Paffenbarger, R. S., Jr. (1995). Exercise intensity and longevity in men. The Harvard alumni health study. JAMA, 273(15), 1179–1184.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.
Baigi, A., Hildingh, C., Virdhall, H., & Fridlund, B. (2008). Sense of coherence as well as social support and network as perceived by patients with a suspected or manifest myocardial infarction: A short-term follow-up study. Clinical Rehabilitation, 22(7), 646–652.
Zahran, H. S., Kobau, R., Moriarty, D. G., Zack, M. M., Holt, J., & Donehoo, R. (2005). Health-related quality of life surveillance—United States, 1993–2002. MMWR Surveillance Summaries, 54(4), 1–35.
Mossey, J. M., & Shapiro, E. (1982). Self-rated health: a predictor of mortality among the elderly. American Journal of Public Health, 72(8), 800–808.
DeSalvo, K. B., Bloser, N., Reynolds, K., He, J., & Muntner, P. (2006). Mortality prediction with a single general self-rated health question. A meta-analysis. Journal of General Internal Medicine, 21(3), 267–275.
Carson, C. (2007). Private practice or academia- making the choice. Urology Times. Feb 2007.
Acknowledgments
Support for this project was provided in part through grants from the Norfolk Foundation, and the US Health Resources Service Administration Department of Health and Human Services. In addition, the project was supported in part by the intramural research program of the NIH, National Institute on Aging. We would like to thank Mr. Brian Main for his help with the patient database.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohan, R., Beydoun, H.A., Beydoun, M.A. et al. Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study. Qual Life Res 20, 713–721 (2011). https://doi.org/10.1007/s11136-010-9805-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-010-9805-3